Q) Not a malignancy associated with lymphoedema? (#Skin tumors)
6000+ High-Yield MCQs & Explanations – NEET SS MCH
Q) Not a malignancy associated with lymphoedema? (#Skin tumors)
Q) All are true regarding ileostomy and IPAAA in PSC with UC except? ( # AIIMS GI, # colon)
1) PSC UC end ileostomy have risk of peristomal varices
2) IPAA for UC nd PSC-UC have same long term results
3) IPAA for PSC-UC have high chronic pouchitis
Q) Surgical Site Infection (SSI) in a clean contaminated wound after prophylaxis is? ( Gen Surgery Infections)
a) 3%
b) 7%
c) 15%
d) 25%
Q) False about post gastrectomy syndrome?
a) 30%incidence
b) Octreotide agonist prevent it's occurrence
c) Megaloblastic anemia due to partial gastrectomy
d) Calcium deficiency in billroth 2
Q) All are true about HPV induced cancers except
a) HPV 16 and 18 cause 70% of all cervical cancers
b) HPV 16. 18. 32 and 38 cause 90% of cervical cancers
c) HPV 6 and 11 cause malignant condyloma acuminata
d) All true
Q) Which of the following is not characteristic of Crohn Disease : * (From AIIMS 2020 November GI)
a) Granular mucosa
b) Transmural involvement
c) Skip lesions
d) Giant cell granuloma
Q) Rate of infection in clean contaminated wound without antibody prophylaxis is
a) 3%
b) 8%
C) 12%
D) 15%
Ans b 8%
Ref Table 5.4
Bailey page 53
Q) Carcinoid syndrome wrong statement is?
a) 40 % have Right heart dysfunction in carcinoid syndrome
b) >1cm in appendix is indication for Right hemi colectomy
c) 30 % jejunoileal carcinoid are metastatic
d) Resection of primary is done in presence of metastatic disease
Q) In Nasopharyngeal carcinoma, Petrosphenoidal syndrome involves which cranial nerves ( Aiims onco 2020) ?
a) VII- X
b) I-III
In This post I will be adding most commonly associated genetic abnormalities and changes
MEN2 syndrome is caused by gain of function mutations in the RET gene.
Li-Fraumeni syndrome is associated with mutation of P53.
Mutations in p16 is associated with melanomas, pancreas, esophagus, head and neck, stomach, breast, and colon.
BRCA1 is associated with breast and ovarian carcinoma.